These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30152571)

  • 21. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
    Najafi R; Sharifi AM
    Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium ion cross-linked sodium alginate hydrogels containing deferoxamine and copper nanoparticles for diabetic wound healing.
    Li S; Wang X; Chen J; Guo J; Yuan M; Wan G; Yan C; Li W; Machens HG; Rinkevich Y; Yang X; Song H; Chen Z
    Int J Biol Macromol; 2022 Mar; 202():657-670. PubMed ID: 35066024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained expression of Hif-1alpha in the diabetic environment promotes angiogenesis and cutaneous wound repair.
    Mace KA; Yu DH; Paydar KZ; Boudreau N; Young DM
    Wound Repair Regen; 2007; 15(5):636-45. PubMed ID: 17971009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice.
    Fine JM; Baillargeon AM; Renner DB; Hoerster NS; Tokarev J; Colton S; Pelleg A; Andrews A; Sparley KA; Krogh KM; Frey WH; Hanson LR
    Exp Brain Res; 2012 Jun; 219(3):381-90. PubMed ID: 22547371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement.
    Fine JM; Kosyakovsky J; Baillargeon AM; Tokarev JV; Cooner JM; Svitak AL; Faltesek KA; Frey WH; Hanson LR
    Brain Behav; 2020 Mar; 10(3):e01536. PubMed ID: 31960628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deferoxamine: potential novel topical therapeutic for chronic wounds.
    Tchanque-Fossuo CN; Dahle SE; Buchman SR; Isseroff RR
    Br J Dermatol; 2017 Apr; 176(4):1056-1059. PubMed ID: 28418133
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibroblast-Specific Deletion of Hypoxia Inducible Factor-1 Critically Impairs Murine Cutaneous Neovascularization and Wound Healing.
    Duscher D; Maan ZN; Whittam AJ; Sorkin M; Hu MS; Walmsley GG; Baker H; Fischer LH; Januszyk M; Wong VW; Gurtner GC
    Plast Reconstr Surg; 2015 Nov; 136(5):1004-1013. PubMed ID: 26505703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel matrix metalloproteinases-cleavable hydrogel loading deferoxamine accelerates diabetic wound healing.
    Li N; Zhan A; Jiang Y; Liu H
    Int J Biol Macromol; 2022 Dec; 222(Pt A):1551-1559. PubMed ID: 36155786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deferoxamine preconditioning activated hypoxia-inducible factor-1α and MyD88-dependent Toll-like receptor 4 signaling in intestinal stem cells.
    Chen Y; Yang XQ; Tseng BY; Tsai YH; Tseng SH; Lee CH; Yao CL
    J Pediatr Surg; 2018 Nov; 53(11):2349-2356. PubMed ID: 29475626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin.
    Li YX; Ding SJ; Xiao L; Guo W; Zhan Q
    Neurosci Bull; 2008 Apr; 24(2):89-95. PubMed ID: 18369388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of deferoxamine on the repair ability of dental pulp cells in vitro.
    Jiang L; Peng WW; Li LF; Du R; Wu TT; Zhou ZJ; Zhao JJ; Yang Y; Qu DL; Zhu YQ
    J Endod; 2014 Aug; 40(8):1100-4. PubMed ID: 25069915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperbaric oxygen therapy activates hypoxia-inducible factor 1 (HIF-1), which contributes to improved wound healing in diabetic mice.
    Sunkari VG; Lind F; Botusan IR; Kashif A; Liu ZJ; Ylä-Herttuala S; Brismar K; Velazquez O; Catrina SB
    Wound Repair Regen; 2015; 23(1):98-103. PubMed ID: 25532619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats.
    Zhu Y; Wang Y; Jia Y; Xu J; Chai Y
    Wound Repair Regen; 2019 Jul; 27(4):324-334. PubMed ID: 30817065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 20(S)-Protopanaxadiol enhances angiogenesis via HIF-1α-mediated VEGF secretion by activating p70S6 kinase and benefits wound healing in genetically diabetic mice.
    Zhang EY; Gao B; Shi HL; Huang LF; Yang L; Wu XJ; Wang ZT
    Exp Mol Med; 2017 Oct; 49(10):e387. PubMed ID: 29075038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injectable Desferrioxamine-Laden Silk Nanofiber Hydrogels for Accelerating Diabetic Wound Healing.
    Ding Z; Zhang Y; Guo P; Duan T; Cheng W; Guo Y; Zheng X; Lu G; Lu Q; Kaplan DL
    ACS Biomater Sci Eng; 2021 Mar; 7(3):1147-1158. PubMed ID: 33522800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.
    Chen H; Jia P; Kang H; Zhang H; Liu Y; Yang P; Yan Y; Zuo G; Guo L; Jiang M; Qi J; Liu Y; Cui W; Santos HA; Deng L
    Adv Healthc Mater; 2016 Apr; 5(8):907-18. PubMed ID: 26891197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues.
    Thangarajah H; Yao D; Chang EI; Shi Y; Jazayeri L; Vial IN; Galiano RD; Du XL; Grogan R; Galvez MG; Januszyk M; Brownlee M; Gurtner GC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13505-10. PubMed ID: 19666581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective deficiency of HIF-1alpha in myeloid cells influences secondary intention wound healing in mouse skin.
    Owings RA; Boerma M; Wang J; Berbee M; Laderoute KR; Soderberg LS; Vural E; Jensen MH
    In Vivo; 2009; 23(6):879-84. PubMed ID: 20023228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of ARNT in myeloid cells causes immune suppression and delayed wound healing.
    Scott C; Bonner J; Min D; Boughton P; Stokes R; Cha KM; Walters SN; Maslowski K; Sierro F; Grey ST; Twigg S; McLennan S; Gunton JE
    Am J Physiol Cell Physiol; 2014 Aug; 307(4):C349-57. PubMed ID: 24990649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Deferoxamine on Vascularity and Soft-Tissue Biomechanics in a Rat TRAM Flap Model.
    Mericli AF; Das A; Rodeheaver P; Rodeheaver GT; Lin KY
    Plast Reconstr Surg; 2015 Jul; 136(1):125e-127e. PubMed ID: 25803154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.